T1D Fund
Morgan Janes, PhD, currently serves as an Associate at T1D Fund and as a Freelance Writer for ACIR. Previously, Morgan completed a Summer Fellowship at MPM Capital and pursued a PhD in Medical Engineering & Medical Physics with a concentration in Biological Engineering at Massachusetts Institute of Technology. Morgan's research involved work in The Mitragotri Laboratory for Drug Delivery at Harvard University. Prior experiences include a VC Fellowship at ARTIS Ventures, undergraduate research at the University of Maryland in Tissue Engineering and Biomaterials, and internships at West Pharmaceutical Services and the University of Maryland School of Medicine, contributing to significant advancements in tissue regeneration and immune receptor discovery. Morgan holds a Bachelor's Degree in Bioengineering from the University of Maryland.
This person is not in the org chart
This person is not in any teams
T1D Fund
The T1D Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent, and ultimately cure T1D. Launched in December 2016, our aim is to attract and deploy capital to advance promising disease-modifying therapies and provide cures for those living with T1D. It’s the first scaled, mission-driven venture philanthropy fund focused on equity investments in partnership with additional sources of capital, including venture capital, corporations, and foundations. By investing in areas strategically aligned with Breakthrough T1D (Formerly JDRF), the leading global T1D research and advocacy organization, we can exclusively focus on supporting innovative approaches and novel mechanisms with curative potential. We are a mission-driven organization that continues to support companies that play a role in the discovery and therapeutic development of effective solutions to T1D.